Company Filing History:
Years Active: 2007-2021
Title: Edwin Claerebout: Innovator in Vaccine Development
Introduction: Edwin Claerebout, an esteemed inventor based in Lokeren, Belgium, has made significant contributions to the field of vaccine development. With a total of five patents to his name, Claerebout's innovative work centers around nucleotide sequences and recombinant DNA molecules that have the potential to induce protective immunity against various infections.
Latest Patents: Among his latest patents is a groundbreaking vaccine that relates to nucleotide sequences encoding antigens. This invention includes recombinant DNA molecules that contain these nucleotide sequences, allowing host cells to express them effectively. Claerebout's work addresses the need for vaccines targeting parasitic nematodes, offering methods for preparing vaccines that can protect against infections caused by species of this genus. Additionally, his development of the Cooperia vaccine utilizes similar methodologies to create vaccines that provide immunity against certain parasitic infections.
Career Highlights: Edwin Claerebout has established himself as a pivotal figure in the field of biotechnology and vaccine research. Working at Universiteit Gent, he has played an integral role in advancing the understanding and availability of vaccines, particularly those targeting complex parasitic infections. His patents not only reflect his technical expertise but also his commitment to public health and innovation.
Collaborations: Throughout his career, Claerebout has collaborated with notable colleagues such as Peter Geldhof and Veerle De Maere. These partnerships have fostered an environment of innovation and creativity, allowing for the exchange of ideas and advancements in vaccine technology.
Conclusion: Edwin Claerebout is a distinguished inventor whose work in vaccine development continues to impact the healthcare landscape positively. With his five patents, he stands at the forefront of innovative solutions to combat infectious diseases, particularly those caused by parasitic nematodes. His contributions are vital in shaping the future of vaccine research and development.